SunOpta (STKL)
(Delayed Data from NSDQ)
$7.29 USD
-0.16 (-2.15%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $7.28 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.29 USD
-0.16 (-2.15%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $7.28 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Zacks News
Vital Farms (VITL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 300% and 17.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SunOpta (STKL) Q3 Earnings Match Estimates
by Zacks Equity Research
SunOpta (STKL) delivered earnings and revenue surprises of 0% and 2.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is MGP Ingredients (MGPI) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how MGP (MGPI) and SunOpta (STKL) have performed compared to their sector so far this year.
What Makes SunOpta (STKL) a Good Fit for "Trend Investing"
by Zacks Equity Research
SunOpta (STKL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Wall Street Analysts Believe SunOpta (STKL) Could Rally 41%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for SunOpta (STKL) points to a 41% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Find Highly-Ranked Cheap Stocks Under $10 to Buy with this Screen
by Benjamin Rains
We used one of our Zacks screens to help show investors how to find strong, highly-ranked stocks that are trading for under $10 per share to consider buying as we start to close out August.
Here's Why SunOpta (STKL) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does SunOpta (STKL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Analysts Initiate Coverage: 5 Stocks to Buy for Higher Returns
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Professional Holding (PFHD), Trinity (TRIN), SunOpta (STKL), Arcos Dorados (ARCO) and Proto Labs (PRLB).
Will SunOpta (STKL) Gain on Rising Earnings Estimates?
by Zacks Equity Research
SunOpta (STKL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Believe SunOpta (STKL) Could Rally 25%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for SunOpta (STKL) points to a 25% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Recent Price Trend in SunOpta (STKL) is Your Friend, Here's Why
by Zacks Equity Research
SunOpta (STKL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
SunOpta (STKL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
SunOpta (STKL) delivered earnings and revenue surprises of 400% and 11.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sysco (SYY) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sysco (SYY) delivered earnings and revenue surprises of 31.48% and 5.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Mondelez (MDLZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 13.51% and 3.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Medifast (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Medifast (MED) and SunOpta (STKL) have performed compared to their sector so far this year.
Forget Bargains, Play 5 Stocks With Rising P/E Instead
by Sanghamitra Saha
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
SunOpta (STKL) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
SunOpta (STKL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for December 22nd
by Zacks Equity Research
APTS, NVMI, STKL, and VRS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 22, 2021.
Zacks.com featured highlights include: SunOpta, Lazydays, Quotient, OptiNose and Motorcar Parts of America
by Zacks Equity Research
Zacks.com featured highlights include: SunOpta, Lazydays, Quotient, OptiNose and Motorcar Parts of America
Rising P/E: An Overlooked Trick to Land on 5 Winning Stocks
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Wall Street Analysts Believe SunOpta (STKL) Could Rally 142%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 141.7% upside potential for SunOpta (STKL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
5 Stocks With Rising P/E Are Good Buys
by Sanghamitra Saha
Bet on top-ranked stocks STKL, LZB, ONCY, TPR and TRVI that have rising P/E to realize outsized gains.
The Zacks Analyst Blog Highlights: Target, Casey's, United Natural Foods and SunOpta
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Target, Casey's, United Natural Foods and SunOpta
4 Grocery Stocks to Buy as Omicron Variant Raises Fresh Fears
by Ritujay Ghosh
Grocery stocks with a strong online presence like Target Corporation (TGT), Casey's General Stores, Inc. (CASY), United Natural Foods (UNFI) and SunOpta, Inc. (STKL) are gaining on fears of a new COVID-19 variant.
SunOpta (STKL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for SunOpta (STKL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.